Meng Qiu

5‑Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma

Mengying Tong, Shuhang Gao, Wenjing Qi et al. · Oncology Letters · 2019 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +17

Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study.

Rui‐Hua Xu, Feng Wang, Gong Chen et al. · Journal of Clinical Oncology · 2024 · 19 citations

Life Sciences, Immunology, Oncology +17

Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study

Gong Chen, Meng Qiu, Jinfeng Ma et al. · Cancer Cell · 2025 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Clinical Characteristics of Patients With Solitary Pulmonary Mass After Radical Treatment for Primary Cancers: Pulmonary Metastasis or Second Primary Lung Cancer?

Jun Ge, Hongfeng Gou, Ye Chen et al. · Cancer Investigation · 2013 · 10 citations

Medicine, Oncology, Surgery +12